Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression
The MDR phenomenon has become a major obstacle in the treatment of cancers, and among the strategies to reverse it, the inhibition of P-gp function and expression is essential to increase for effective anticancer drugs. In the present paper, the co-delivery of berberine chloride and tariquidar loade...
Main Authors: | Giulia Vanti, Marcella Coronnello, Daniele Bani, Antonella Mannini, Maria Camilla Bergonzi, Anna Rita Bilia |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
MDPI AG
2021-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Acceso en liña: | https://www.mdpi.com/1999-4923/13/3/306 |
Títulos similares
-
PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers
por: Jinling Yu, et al.
Publicado: (2020-03-01) -
Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ
por: Ruoshi Zhang, et al.
Publicado: (2020-05-01) -
Berberine Chloride is an Alphavirus Inhibitor That Targets Nucleocapsid Assembly
por: Judy J. Wan, et al.
Publicado: (2020-06-01) -
Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro
por: Bruno A. Rodriguez-Rodriguez, et al.
Publicado: (2021-12-01) -
Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells
por: Chang Hyun Kim, et al.
Publicado: (2023-02-01)